April 30 (Reuters) - Keymed Biosciences Inc :
* NEW DRUG APPLICATION OF STAPOKIBART INJECTION FOR TREATMENT OF SEASONAL ALLERGIC RHINITIS ACCEPTED BY NMPA
Further company coverage:
((Reuters.Briefs@thomsonreuters.com;))
April 30 (Reuters) - Keymed Biosciences Inc :
* NEW DRUG APPLICATION OF STAPOKIBART INJECTION FOR TREATMENT OF SEASONAL ALLERGIC RHINITIS ACCEPTED BY NMPA
Further company coverage:
((Reuters.Briefs@thomsonreuters.com;))
Comments